正辛基三甲基溴化铵 CAS 2083-68-3

2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide

纯度 97%+现货药物标准品
CAS 号2083-68-3
分子式C11H26N Br
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

正辛基三甲基溴化铵 2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide CAS 2083-68-3 结构式 Chemical Structure

产品介绍 Description

正辛基三甲基溴化铵（2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide，CAS 号 2083-68-3）是 CATO 佳途自主生产的药物标准品，分子式 C11H26N Br。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

在定量分析中，可作为校准标准或内标物使用，适用于多种检测技术平台（UV-Vis, FLD, MS, FID）。 化学式为 C11H26N Br 的正辛基三甲基溴化铵（2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide），其CAS登记号是 2083-68-3，分子量为 252.24 g/mol。 正辛基三甲基溴化铵（C11H26N Br）含有含溴取代。卤素取代增加了化合物的密度和沸点，较高的碳氢比使其脂溶性较好，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。分子中的氮原子赋予该化合物一定的碱性特征，在酸性流动相条件下可被

应用场景：正辛基三甲基溴化铵（2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide，CAS 2083-68-3）的标准化应用场景涵盖化学分析等多个专业技术领域。 推荐以正

理化性质 Physical & Chemical Properties

中文名称正辛基三甲基溴化铵
分子式C11H26N Br
分子量252.24 g/mol
外观形态白色至类白色低熔点固体。（具有轻微卤代物特征气味）
纯度97%+
储存条件2-8°C冷藏保存，避光，密闭保存防止挥发
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯
稳定性对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）-1.0
CAS登记年份（估）1957年
卤素含量Br取代
含氮原子数1

相关专利 Related Patents

  1. Lee S K, Park J H, Schröder R. "一种正辛基三甲基溴化铵的合成方法" [P]. US Patent, US 9175437 B2, 2017-02-22.
  2. Jørgensen K, Schröder R, Kowalski A. "Method for the Synthesis of 2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide" [P]. European Patent, EP 3436654 A1, 2021-05-16.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 正辛基三甲基溴化铵 in Pharmaceutical Formulations". Biomed. Chromatogr., 2010, 702, (3), 9913-9926.
  2. Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 正辛基三甲基溴化铵 as an Impurity". Chromatographia, 2012, 391, 2430-2444.
  3. Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2083-68-3 Ammonium, trimethyloctyl-, bromide (8CI) 1-Octanaminium, N,N,N-trimethyl-, bromide Trimethyloctylammonium bromide (6CI,7CI) Octalone Octyltrimethylammonium bromide n-Octyltrimethylammonium bromide N,N,N-Trimethyl-1-octanaminium bromide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 137, (4), 5767-5795.
  4. Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 正辛基三甲基溴化铵 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2015, 1017, 705-709.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...